77 related articles for article (PubMed ID: 14706631)
1. Leukaemia inhibitory factor or oncostatin M induction of Swiss 3T3 cells does not require mevalonic acid synthesis nor protein isoprenylation to initiate DNA replication.
Sauane M; Coso OA; Giulianelli S; Giráldez AN; Rudland PS; Jimenez de Asua L
Biochem Biophys Res Commun; 2004 Jan; 313(4):926-30. PubMed ID: 14706631
[TBL] [Abstract][Full Text] [Related]
2. Mevalonate dependency of the early cell cycle mitogenic response to epidermal growth factor and prostaglandin F2 alpha in Swiss mouse 3T3 cells.
Ortiz MB; Goin M; Gomez de Alzaga MB; Hammarstrom S; Jimenez de Asua L
J Cell Physiol; 1995 Jan; 162(1):139-46. PubMed ID: 7814446
[TBL] [Abstract][Full Text] [Related]
3. Leukemia inhibitory factor induces DNA synthesis in Swiss mouse 3T3 cells independently of cyclin D1 expression through a mechanism involving MEK/ERK1/2 activation.
Dekanty A; Sauane M; Cadenas B; Coluccio F; Barrio M; Casala J; Paciencia M; Rogers F; Coso OA; Piwien-Pilipuk G; Rudland PS; de Asúa LJ
J Biol Chem; 2006 Mar; 281(10):6136-43. PubMed ID: 16291739
[TBL] [Abstract][Full Text] [Related]
4. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor impairs cell p4fferentiation in cultured adipogenic cells (3T3-L1).
Nishio E; Tomiyama K; Nakata H; Watanabe Y
Eur J Pharmacol; 1996 Apr; 301(1-3):203-6. PubMed ID: 8773465
[TBL] [Abstract][Full Text] [Related]
5. Isoprenoid alcohols restore protein isoprenylation in a time-dependent manner independent of protein synthesis.
Ownby SE; Hohl RJ
Lipids; 2003 Jul; 38(7):751-9. PubMed ID: 14506838
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of osteoclast differentiation in vitro by mouse oncostatin M, leukaemia inhibitory factor, cardiotrophin-1 and interleukin 6: synergy with dexamethasone.
Richards CD; Langdon C; Deschamps P; Pennica D; Shaughnessy SG
Cytokine; 2000 Jun; 12(6):613-21. PubMed ID: 10843736
[TBL] [Abstract][Full Text] [Related]
7. Lovastatin inhibits proliferation of rat mesangial cells.
O'Donnell MP; Kasiske BL; Kim Y; Atluru D; Keane WF
J Clin Invest; 1993 Jan; 91(1):83-7. PubMed ID: 8423236
[TBL] [Abstract][Full Text] [Related]
8. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M.
Schrell UM; Koch HU; Marschalek R; Schrauzer T; Anders M; Adams E; Fahlbusch R
J Neurosurg; 1998 Mar; 88(3):541-8. PubMed ID: 9488310
[TBL] [Abstract][Full Text] [Related]
9. Oncostatin M is a differentiation factor for myeloid leukemia cells.
Bruce AG; Hoggatt IH; Rose TM
J Immunol; 1992 Aug; 149(4):1271-5. PubMed ID: 1380037
[TBL] [Abstract][Full Text] [Related]
10. Role of the mevalonate pathway of isoprenoid synthesis in IL-8 generation by activated monocytic cells.
Terkeltaub R; Solan J; Barry M; Santoro D; Bokoch GM
J Leukoc Biol; 1994 Jun; 55(6):749-55. PubMed ID: 8195701
[TBL] [Abstract][Full Text] [Related]
11. Suppression of invasion and MMP-9 expression in NIH 3T3 and v-H-Ras 3T3 fibroblasts by lovastatin through inhibition of ras isoprenylation.
Wang IK; Lin-Shiau SY; Lin JK
Oncology; 2000 Sep; 59(3):245-54. PubMed ID: 11053993
[TBL] [Abstract][Full Text] [Related]
12. Lovastatin-induced proliferation inhibition and apoptosis in C6 glial cells.
Choi JW; Jung SE
J Pharmacol Exp Ther; 1999 Apr; 289(1):572-9. PubMed ID: 10087052
[TBL] [Abstract][Full Text] [Related]
13. Oncostatin M-specific receptor expression and function in regulating cell proliferation of normal and malignant mammary epithelial cells.
Liu J; Hadjokas N; Mosley B; Estrov Z; Spence MJ; Vestal RE
Cytokine; 1998 Apr; 10(4):295-302. PubMed ID: 9617575
[TBL] [Abstract][Full Text] [Related]
14. Mitogenic effect of lithium in FRTL-5 cells can be reversed by blocking de novo cholesterol synthesis and subsequent signal transduction.
Tasevski V; Benn D; King M; Luttrell B; Simpson A
Thyroid; 2000 Apr; 10(4):305-11. PubMed ID: 10807058
[TBL] [Abstract][Full Text] [Related]
15. Effect of inhibition of cholesterol synthetic pathway on the activation of Ras and MAP kinase in mesangial cells.
Bassa BV; Roh DD; Vaziri ND; Kirschenbaum MA; Kamanna VS
Biochim Biophys Acta; 1999 Mar; 1449(2):137-49. PubMed ID: 10082972
[TBL] [Abstract][Full Text] [Related]
16. Lovastatin induces apoptosis in malignant mesothelioma cells.
Rubins JB; Greatens T; Kratzke RA; Tan AT; Polunovsky VA; Bitterman P
Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1616-22. PubMed ID: 9603146
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor γ down-regulation mediates the inhibitory effect of d-δ-tocotrienol on the differentiation of murine 3T3-F442A preadipocytes.
Torabi S; Yeganehjoo H; Shen CL; Mo H
Nutr Res; 2016 Dec; 36(12):1345-1352. PubMed ID: 27884413
[TBL] [Abstract][Full Text] [Related]
18. Oncostatin M and interleukin 6 inhibit cell cycle progression by prevention of p27kip1 degradation in HepG2 cells.
Klausen P; Pedersen L; Jurlander J; Baumann H
Oncogene; 2000 Jul; 19(32):3675-83. PubMed ID: 10951574
[TBL] [Abstract][Full Text] [Related]
19. Regulatory role of mevalonate and N-linked glycosylation in proliferation and expression of the EWS/FLI-1 fusion protein in Ewing's sarcoma cells.
Wang M; Xie Y; Girnita L; Nilsson G; Dricu A; Wejde J; Larsson O
Exp Cell Res; 1999 Jan; 246(1):38-46. PubMed ID: 9882513
[TBL] [Abstract][Full Text] [Related]
20. Cloning and biological activity of murine oncostatin M.
Hara T; Ichihara M; Yoshimura A; Miyajima A
Leukemia; 1997 Apr; 11 Suppl 3():449-50. PubMed ID: 9209421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
